FCGR1A and myeloid sarcoma: A recent study has shown an increase in circulating classical monocytes with pro-inflammatory M1 macrophage markers in MS (CD86, CD64, CD32), as well as regulatory M2 macrophage markers (CD206, CD209, PD-L1) [62].